Health Condition 1: J00-J99- Diseases of the respiratory system Health Condition 2: J00-J99- Diseases of the respiratory system
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subjects who have recovered from COVID-19 (RTPCR - negative) having history of mild, moderate, severe infection will be included in the study with persistence of symptoms or development of general sequelae (fatigue, joint pain, muscular pain and fever) beyond 3 or 4â??weeks from the onset of acute symptoms of COVID-19 2.Subjects without any bar of race, religion and gender.
Exclusion criteria
Exclusion criteria: 1.Patient less than 21 yrs. and above 60yrs. of age will be excluded. 2.The pregnant women and lactating mother will be excluded. 3.Patients who have completed participation in any other clinical trial during the past six months. 4.Patients with co-morbidities like Chronic Obstructive Pulmonary disease (COPD), Ischemic Heart Disease (IHD), Chronic Kidney Disease (CKD), coagulopathy and cancer. 5.Patients who were on immuno-suppressant, oral steroids or chemotherapy. 6.Patients k/c/o Diabetes Mellitus (DM) taking insulin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant relief in symptoms of post COVID 19 in general sequelae. (Aartasya Rognut effect of Rasyana Churan Vati will be expected )Timepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in Quality of LifeTimepoint: 8 weeks | — |
Countries
India
Contacts
All India Institute of Ayurveda, Sarita Vihar, New Delhi